Clinical and Molecular Characteristics of High-Risk, Recurrent, or Metastatic Endometrial Cancer That Is Human Epidermal Growth Factor Receptor 2–Low A double-blind placebo-controlled phase III trial ...

Comprehensive Breast Cancer Risk Assessment for CHEK2 and ATM Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick Model A novel Fixed-Stratified method was developed ...

In two clinical trials of the vascular endothelial growth factor (VEGF) receptor inhibitor pazopanib in advanced renal cell carcinoma (mRCC), we found interleukin-6 as predictive of pazopanib benefit.

Patient-centered care for diabetes must integrate psychosocial factors and diabetes technology, according to an Endocrine Society position statement. Patient-centered care for individuals with ...